Literature DB >> 19041781

Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells.

Maria C N Marchetto1, Alysson R Muotri, Yangling Mu, Alan M Smith, Gabriela G Cezar, Fred H Gage.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by motor neuron death. ALS can be induced by mutations in the superoxide dismutase 1 gene (SOD1). Evidence for the non-cell-autonomous nature of ALS emerged from the observation that wild-type glial cells extended the survival of SOD1 mutant motor neurons in chimeric mice. To uncover the contribution of astrocytes to human motor neuron degeneration, we cocultured hESC-derived motor neurons with human primary astrocytes expressing mutated SOD1. We detected a selective motor neuron toxicity that was correlated with increased inflammatory response in SOD1-mutated astrocytes. Furthermore, we present evidence that astrocytes can activate NOX2 to produce superoxide and that effect can be reversed by antioxidants. We show that NOX2 inhibitor, apocynin, can prevent the loss of motor neurons caused by SOD1-mutated astrocytes. These results provide an assay for drug screening using a human ALS in vitro astrocyte-based cell model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041781     DOI: 10.1016/j.stem.2008.10.001

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  220 in total

1.  Human stem cells as a model of motoneuron development and diseases.

Authors:  Yan Liu; Su-Chun Zhang
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

2.  Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity.

Authors:  Qiang Li; Netanya Y Spencer; Nicholas J Pantazis; John F Engelhardt
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

3.  Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis.

Authors:  Pablo Díaz-Amarilla; Silvia Olivera-Bravo; Emiliano Trias; Andrea Cragnolini; Laura Martínez-Palma; Patricia Cassina; Joseph Beckman; Luis Barbeito
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-18       Impact factor: 11.205

Review 4.  NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.

Authors:  Hui-Ming Gao; Hui Zhou; Jau-Shyong Hong
Journal:  Trends Pharmacol Sci       Date:  2012-04-11       Impact factor: 14.819

Review 5.  Cellular reprogramming: a new technology frontier in pharmaceutical research.

Authors:  Amy Brock; Hui-Tong Goh; Binxia Yang; Yu Lu; Hu Li; Yuin-Han Loh
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

Review 6.  Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells.

Authors:  M Nizzardo; C Simone; M Falcone; F Locatelli; G Riboldi; G P Comi; S Corti
Journal:  Cell Mol Life Sci       Date:  2010-07-29       Impact factor: 9.261

7.  What can pluripotent stem cells teach us about neurodegenerative diseases?

Authors:  Hynek Wichterle; Serge Przedborski
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

Review 8.  Induced pluripotent stem cells: the new patient?

Authors:  Milena Bellin; Maria C Marchetto; Fred H Gage; Christine L Mummery
Journal:  Nat Rev Mol Cell Biol       Date:  2012-10-04       Impact factor: 94.444

9.  Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.

Authors:  Andrea Crotti; Christopher Benner; Bilal E Kerman; David Gosselin; Clotilde Lagier-Tourenne; Chiara Zuccato; Elena Cattaneo; Fred H Gage; Don W Cleveland; Christopher K Glass
Journal:  Nat Neurosci       Date:  2014-03-02       Impact factor: 24.884

Review 10.  Stem cells in the nervous system.

Authors:  Angel R Maldonado-Soto; Derek H Oakley; Hynek Wichterle; Joel Stein; Fiona K Doetsch; Christopher E Henderson
Journal:  Am J Phys Med Rehabil       Date:  2014-11       Impact factor: 2.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.